Cellectis
CLLS
38 hedge funds and large institutions have $184M invested in Cellectis in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 7 closing their positions.
407% more capital inflows, than outflows
Capital inflows: $17.5M | Capital outflows: $3.45M
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
1.03% more ownership
Funds ownership: 14.22% → 15.25% (+1%)
14% less funds holding
Funds holding: 44 → 38 (-6)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Perceptive Advisors
New York
|
+$5.29M |
| 2 |
Millennium Management
New York
|
+$4.32M |
| 3 |
THSP
Taube Hodson Stonex Partners
London,
United Kingdom
|
+$2.92M |
| 4 |
Cabot Wealth Management
Salem,
Massachusetts
|
+$929K |
| 5 |
Cormorant Asset Management
Boston,
Massachusetts
|
+$849K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vident Investment Advisory
Alpharetta,
Georgia
|
-$722K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$625K |
| 3 |
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$513K |
| 4 |
Trexquant Investment
Stamford,
Connecticut
|
-$347K |
| 5 |
Deltec Asset Management
New York
|
-$330K |
CLLS Hedge Fund Activity: Q2 2016 in Review
38 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2016, worth a combined $184M — up 3.7% from $178M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CLLS and 2 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 15 added.
The largest buyer was Perceptive Advisors, adding an estimated $5.29M. The largest seller was Vident Investment Advisory, cutting an estimated $722K.
- 38 institutional investors held Cellectis (CLLS) as of Q2 2016, down from 44 in Q1 2016.
- Funds reported $184M of Cellectis stock for Q2 2016, up 3.7% quarter-over-quarter.
- 2 funds opened new Cellectis positions in Q2 2016 and 7 closed out, a net change of -5 holders.
- The largest Cellectis buyer in Q2 2016 was Perceptive Advisors, an estimated $5.29M added.
- The largest Cellectis seller in Q2 2016 was Vident Investment Advisory, an estimated $722K sold.
Based on aggregated 13F filings for Q2 2016.